Bristol Myers Squibb (CELG-RI) Asset Utilization Ratio (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 17 years of Asset Utilization Ratio data on file, last reported at 0.55 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.55, up 6.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.55 (up 6.69% YoY), and the FY2025 annual result was 0.53, up 2.58% from the prior year.
• Asset Utilization Ratio climbed to 0.55 in Q1 2026 per CELG-RI's latest filing, from 0.52 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.55 in Q1 2026 and troughed at 0.44 in Q1 2022.
• A 5-year average of 0.49 and a median of 0.48 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio increased 19.29% in 2022, then retreated 2.26% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.47 in 2022, then advanced by 2.0% to 0.48 in 2023, then advanced by 7.4% to 0.52 in 2024, then decreased by 0.57% to 0.52 in 2025, then advanced by 6.53% to 0.55 in 2026.
• Business Quant data shows CELG-RI's Asset Utilization Ratio at 0.55 in Q1 2026, 0.52 in Q4 2025, and 0.5 in Q3 2025.